Embecta (EMBC) reported $1.1B in revenue for fiscal 2025, −3.8% year on year. That ranks #1728 by revenue among 2853 SEC filers and #158 in Healthcare. Net income was $95.4M, a net margin of 8.8%. Revenue has declined 0.1% a year on average since 2020 ($1.1B then). The fiscal 2025 balance sheet shows $1.1B in total assets, $201M in cash and $1.4B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.1B | −3.8% | FY20252025-09-30 |
| Gross profitGrossProfit | $677M | −7.9% | FY20252025-09-30 |
| Operating incomeOperatingIncomeLoss | $242M | +45.1% | FY20252025-09-30 |
| Net incomeNetIncomeLoss | $95.4M | +21.8% | FY20252025-09-30 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $192M | +437.0% | FY20252025-09-30 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $9.3M | −41.1% | FY20252025-09-30 |
| Total assetsAssets | $1.1B | −7.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | −$613M | +$156M | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $201M | −4.1% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $1.4B | −11.8% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $222M | −$4.1M | Open → |
| Q2 20262026-06-30 | $272M | $21.1M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 62 of 161 companies compared | 8.8% | |
| Operating marginRank 28 of 160 companies compared | 22.4% | |
| R&D as share of revenueRank 86 of 102 companies compared | 3.5% | |
| Cash as share of revenueRank 58 of 160 companies compared | 18.6% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Embecta Corp.
- Ticker
- EMBC
- Exchange
- Nasdaq
- SIC classification
- Surgical & Medical Instruments & Apparatus (3841)
- Fiscal year end
- 09-30
- CIK
- 0001872789
Filings
- 10-QAug 7, 2026Open filing →
- 10-QMay 5, 2026Open filing →
- 10-QFeb 5, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Sotera HealthSHC | $1.2B | $77.9M |
| NovavaxNVAX | $1.1B | $440M |
| Prestige Consumer HealthcarePBH | $1.1B | $190M |
| EmbectaEMBC | $1.1B | $95.4M |
| Acadia PharmaceuticalsACAD | $1.1B | $391M |
| Legend BiotechLEGN | $1.0B | −$297M |
| Tandem Diabetes CareTNDM | $1.0B | −$205M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Embecta — Key figures |url=https://companiesranked.com/en/company/embecta |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Embecta — Key figures. CompaniesRanked. https://companiesranked.com/en/company/embectaBibTeX
@misc{companiesranked-en-company-embecta-2026,
author = {{CompaniesRanked}},
title = {{Embecta — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/embecta}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.